Showing results (1071-1080 of 1,525) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2025
A Quantitative Systems Pharmacology Model That Describes Neurofilament Light Dynamics During Alzheimer's Disease ProgressionPolina Maliukova, Tatiana KarelinaCPT: Pharmacometrics & Systems Pharmacology|June 17, 2025
Evaluation of Four Semi-Mechanistic Models for Predicting Glycemic Control With a Glucagon Receptor Antagonist in People With Type 2 DiabetesAustin Yue Feng Tan, Karen Schneck, Parag Garhyan, et al.CPT: Pharmacometrics & Systems Pharmacology|April 3, 2025
Using the Simcyp R Package for PBPK Simulation Workflows With the Simcyp SimulatorAnthonia M Onasanwo, Naresh Mittapelly, Laura Shireman, et al.CPT: Pharmacometrics & Systems Pharmacology|March 17, 2025
Population Pharmacokinetics and Exposure-Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial HypercholesterolemiaSébastien Bihorel, Robert Dingman, Jeanne Mendell, et al.CPT: Pharmacometrics & Systems Pharmacology|February 21, 2026
Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025Henrik Cordes, Pieter Annaert, Pavel Balazki, et al.CPT: Pharmacometrics & Systems Pharmacology|February 19, 2026
Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell TransplantationMourad Mseddi, Christa Nath, Khalil Ben Hassine, et al.CPT: Pharmacometrics & Systems Pharmacology|February 23, 2026
Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic RecirculationCedric Lau, Charlotte van Kesteren, Robert M Smeenk, et al.CPT: Pharmacometrics & Systems Pharmacology|February 9, 2024
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseasesFarzaneh Maleki, Elias Clark, Christopher Banfield, et al.CPT: Pharmacometrics & Systems Pharmacology|February 2, 2024
Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patientsMagali Amiel, Alice Ke, Steven P Gelone, et al.CPT: Pharmacometrics & Systems Pharmacology|March 29, 2024
Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in childrenEstefania Traver, Laura Rodríguez-Pascau, Uwe Meya, et al.Pageof 153